|
|
| | T-Peptide Basic information |
| Product Name: | T-Peptide | | Synonyms: | T-Peptide;L-Argininamide, N-acetyl-D-valyl-D-glutaminyl-D-isoleucyl-D-valyl-D-tyrosyl-D-lysyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-;Ac-VQIVYKRRRRRRRRR-NH2;T-peptide TFA | | CAS: | 2022956-62-1 | | MF: | C92H171N45O18 | | MW: | 2195.63 | | EINECS: | | | Product Categories: | | | Mol File: | 2022956-62-1.mol |  |
| | T-Peptide Chemical Properties |
| density | 1.50±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO |
| | T-Peptide Usage And Synthesis |
| Uses | T-peptide, a Tuftsin analog, can be used for the research of human immunodeficiency virus (HIV) infection. T-peptide prevents cellular immunosuppression and improves survival rate in septic mice. T-peptide also can inhibit the growth of residual tumor cells after surgical resection[1][2]. | | References | [1] Simpson DM, et, al. Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group. Neurology. 1996 Nov;47(5):1254-9. DOI:10.1212/wnl.47.5.1254
[2] Gao YL, et, al. Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice. Sci Rep. 2015 Nov 18;5:16725. DOI:10.1038/srep16725 |
| | T-Peptide Preparation Products And Raw materials |
|